INSMED Inc

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Total Revenue $0 $0 $9.8m
$136.5m +1287.56%
$164.4m +20.48%
$188.5m +14.63%
$245.4m +30.19%
$305.2m +24.39%
$363.7m +19.17%
$606.4m +66.73%
$1.1b +87.60%
Cost of Revenue $0 $0 $2.4m
$24.2m +899.26%
$39.9m +64.68%
$44.2m +10.73%
$55.1m +24.86%
$65.6m +18.95%
$85.7m +30.76%
$122.9m +43.38%
$188.2m +53.10%
Gross Profit (derived) $0 $0 $7.4m
$112.3m +1414.50%
$124.5m +10.94%
$144.3m +15.87%
$190.2m +31.82%
$239.6m +25.97%
$278.0m +16.00%
$483.5m +73.94%
$949.4m +96.37%
Research and Development Expense $122.7m $109.7m $145.3m $131.7m $181.2m $272.7m $397.5m $571.0m $598.4m $771.1m $860.8m
General and Administrative Expense $50.7m $79.2m $168.2m $210.8m $203.6m $234.3m $265.8m $344.5m $461.1m $701.2m $893.6m
Amortization of Intangible Assets $0 $0 $1.2m $5.0m $5.0m $5.1m $5.1m $5.1m $5.1m $6.0m
Operating Lease, Expense $3.2m $3.7m $4.9m $8.0m $9.2m $11.9m $13.6m
Operating Expenses $173.4m $188.9m $317.2m $347.5m $429.6m $563.6m $702.7m $1.0b $1.2b $1.9b $1.8b
Operating Income (Loss) ($173.4m)
($188.9m) -8.95%
($307.3m) -62.68%
($235.2m) +23.46%
($265.2m) -12.75%
($375.1m) -41.42%
($457.3m) -21.92%
($709.6m) -55.17%
($878.3m) -23.76%
($1.2b) -41.96%
($812.6m) +34.82%
Interest Expense, Debt $7.9m $7.9m $8.1m $75.8m
Investment income $604k $1.6m $10.3m $9.9m $1.7m $174k $11.1m $42.1m $53.3m $60.7m
Other Nonoperating Income (Expense) $119k $300k $602k ($531k) $405k ($3.3m) ($5.9m) $1.9m $29k ($1.8m)
Interest Expense (non-operating) $3.5m $5.9m $25.5m $27.7m $29.6m $40.5m $26.4m $81.7m $84.9m $83.8m $75.8m
Income (Loss) from Continuing Operations before Income Taxes, Domestic ($140.4m) ($136.7m) ($286.2m) ($201.2m) ($207.1m) ($348.8m) ($406.3m) ($666.2m) ($814.5m) ($1.1b) ($869.1m)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest ($176.2m) ($192.9m) ($324.1m) ($253.6m) ($292.7m) ($436.4m) ($480.2m) ($747.0m) ($910.1m) ($1.3b) ($869.1m)
Provision for income taxes $98k ($272k) $201k $777k $1.4m ($1.8m) $1.4m $2.6m $3.7m $5.0m
Current Income Tax Expense (Benefit) $98k $145k $201k $777k $1.4m $1.7m $1.6m $2.6m $3.7m $5.1m $6.2m
Net loss ($176.3m) ($192.6m) ($324.3m) ($254.3m) ($294.1m) ($434.7m) ($481.5m) ($749.6m) ($913.8m) ($1.3b)
Net Income (Loss) Attributable to Parent ($176.3m)
($192.6m) -9.29%
($324.3m) -68.33%
($254.3m) +21.57%
($294.1m) -15.63%
($434.7m) -47.80%
($481.5m) -10.79%
($749.6m) -55.66%
($913.8m) -21.91%
($1.3b) -39.73%
($875.3m) +31.44%
Earnings Per Share, Basic ($2.85) ($2.89) ($4.22) ($3.01) ($3.01) ($3.88) ($3.91) ($5.34) ($5.57) ($6.42) ($4.12)
Earnings Per Share, Diluted ($2.85) ($2.89) ($4.22) ($3.01) ($3.01) ($3.88) ($3.91) ($5.34) ($5.57) ($6.42) ($4.12)
Weighted Average Number of Shares Outstanding, Basic 61.9m 66.6m 76.9m 84.6m 97.6m 112.1m 123.0m 140.4m 164.0m 199.0m 214.7m
Weighted average basic common shares outstanding (in shares) 61.9m 66.6m 76.9m 84.6m 97.6m 112.1m 123.0m 140.4m 164.0m 199.0m
Weighted average diluted common shares outstanding (in shares) 61.9m 66.6m 76.9m 84.6m 97.6m 112.1m 123.0m 140.4m 164.0m 199.0m
Weighted Average Number of Shares Outstanding, Diluted 61.9m 66.6m 76.9m 84.6m 97.6m 112.1m 123.0m 140.4m 164.0m 199.0m 214.7m
Additional Financial Items
Costs and Expenses $173.4m $188.9m $317.2m $347.5m $429.6m $563.6m $702.7m $1.0b $1.2b $1.9b
Change in fair value of deferred and contingent consideration $0 $0 $7.3m ($20.8m) $28.7m $91.7m $252.0m
Change in fair value of interest rate swap $0 $0 ($1.5m) $320k ($236k) $0
Other (expense) income, net $119k $300k $602k ($531k) $405k ($3.3m) ($5.9m) $1.9m $29k ($1.8m)
Foreign currency translation gains (losses) ($65k) $62k ($6k) ($1k) $203k $775k $303k ($2.2m) ($1.9m) $3.3m
Unrealized gain on marketable securities $0 $0 ($515k) $713k $311k $444k
Total comprehensive loss ($176.3m) ($192.6m) ($324.3m) ($254.3m) ($293.9m) ($433.9m) ($481.7m) ($751.1m) ($915.3m) ($1.3b)

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.